» Articles » PMID: 33803852

Shiga Toxins: An Update on Host Factors and Biomedical Applications

Overview
Journal Toxins (Basel)
Publisher MDPI
Specialty Toxicology
Date 2021 Apr 3
PMID 33803852
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Shiga toxins (Stxs) are classic bacterial toxins and major virulence factors of toxigenic and enterohemorrhagic (EHEC). These toxins recognize a glycosphingolipid globotriaosylceramide (Gb3/CD77) as their receptor and inhibit protein synthesis in cells by cleaving 28S ribosomal RNA. They are the major cause of life-threatening complications such as hemolytic uremic syndrome (HUS), associated with severe cases of EHEC infection, which is the leading cause of acute kidney injury in children. The threat of Stxs is exacerbated by the lack of toxin inhibitors and effective treatment for HUS. Here, we briefly summarize the Stx structure, subtypes, in vitro and in vivo models, Gb3 expression and HUS, and then introduce recent studies using CRISPR-Cas9-mediated genome-wide screens to identify the host cell factors required for Stx action. We also summarize the latest progress in utilizing and engineering Stx components for biomedical applications.

Citing Articles

Overview of Bacterial Protein Toxins from Pathogenic Bacteria: Mode of Action and Insights into Evolution.

Popoff M Toxins (Basel). 2024; 16(4).

PMID: 38668607 PMC: 11054074. DOI: 10.3390/toxins16040182.


Gaining New Insights into Fundamental Biological Pathways by Bacterial Toxin-Based Genetic Screens.

Tian S, Zhou N Bioengineering (Basel). 2023; 10(8).

PMID: 37627769 PMC: 10451959. DOI: 10.3390/bioengineering10080884.


AB Toxins as High-Affinity Ligands for Cell Targeting in Cancer Therapy.

Marquez-Lopez A, Fanarraga M Int J Mol Sci. 2023; 24(13).

PMID: 37446406 PMC: 10343017. DOI: 10.3390/ijms241311227.


Clickable Shiga Toxin B Subunit for Drug Delivery in Cancer Therapy.

Danielewicz N, Rosato F, Tomisch J, Graber J, Wiltschi B, Striedner G ACS Omega. 2023; 8(17):15406-15421.

PMID: 37151527 PMC: 10157870. DOI: 10.1021/acsomega.3c00667.


Advanced Situation with Recombinant Toxins: Diversity, Production and Application Purposes.

Efremenko E, Aslanli A, Lyagin I Int J Mol Sci. 2023; 24(5).

PMID: 36902061 PMC: 10003545. DOI: 10.3390/ijms24054630.


References
1.
Keusch J, Manzella S, Nyame K, Cummings R, Baenziger J . Cloning of Gb3 synthase, the key enzyme in globo-series glycosphingolipid synthesis, predicts a family of alpha 1, 4-glycosyltransferases conserved in plants, insects, and mammals. J Biol Chem. 2000; 275(33):25315-21. DOI: 10.1074/jbc.M002630200. View

2.
Ryou J, Sohn Y, Hwang D, Park W, Kim N, Heo W . Engineering of bacterial exotoxins for highly efficient and receptor-specific intracellular delivery of diverse cargos. Biotechnol Bioeng. 2016; 113(8):1639-46. DOI: 10.1002/bit.25935. View

3.
Fuller C, Pellino C, Flagler M, Strasser J, Weiss A . Shiga toxin subtypes display dramatic differences in potency. Infect Immun. 2011; 79(3):1329-37. PMC: 3067513. DOI: 10.1128/IAI.01182-10. View

4.
Oldham R, Faber M, Keppel T, Buchberger A, Waas M, Hari P . Discovery and validation of surface -glycoproteins in MM cell lines and patient samples uncovers immunotherapy targets. J Immunother Cancer. 2020; 8(2). PMC: 7418848. DOI: 10.1136/jitc-2020-000915. View

5.
Pacheco A, Lazarus J, Sit B, Schmieder S, Lencer W, Blondel C . CRISPR Screen Reveals that EHEC's T3SS and Shiga Toxin Rely on Shared Host Factors for Infection. mBio. 2018; 9(3). PMC: 6016243. DOI: 10.1128/mBio.01003-18. View